Arbutus Biopharma Corporation · NASDAQ:ABUS
Two Seas Capital LP reported a 9.40% stake in Arbutus Biopharma Corporation (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Two Seas Capital LP reported a 9.40% stake in Arbutus Biopharma Corporation, 18,557,543 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 18,557,543
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Two Seas Capital LP | 9.40% | 18,557,543 |
| Two Seas Capital GP LLC | 9.40% | 18,557,543 |
| Sina Toussi | 9.40% | 18,557,543 |
Source
Related
- Arbutus Biopharma Corporation
- Two Seas Capital LP
- Arbutus Biopharma Corporation shareholders
- Schedule 13G/A · Two Seas Capital LP · Feb 17, 2026
- Schedule 13G · Two Seas Capital LP · Aug 13, 2025
- Form 4 · Androski Lindsay · Oct 7, 2026
- Form 4 · Sawhney Roger · Oct 7, 2026
- Form 4 · Nguyen Tuan · Oct 7, 2026
- Form 4 · Beardsley Robert A · Oct 7, 2026
- Schedule 13G/A · Morgan Stanley · Oct 7, 2026